MOMO'S BREAKOUT BOARD

[$ubmachine]

ACIU @$2.33 has key protein for early Parkinson detection in pipeline!

Rare gem and $$$-making opportunity here!

ACIU had the most number of Alpha Synuclein drugs under development in 2022!!!
In their Parkinson related Clinical stage program ACI-7104 and ACI-12589 are on alpha-synuclein for Parkinsons desease.
In their Parkinson related Novel targets program Anti-a-syn antibody and Morphomer® a-syn aggregation inhibitor are on alpha-synuclein for Parkinsons desease.

See complete ACIU pipeline here:
https://www.acimmune.com/pipeline/" rel="nofollow" target="_blank" >https://www.acimmune.com/pipeline/

Alpha Synuclein is key protein which now plays main role in today`s Parkinson Breakthrough News from MJFF:
MICHAEL J. FOX FOUNDATION ANNOUNCES SIGNIFICANT BREAKTHROUGH IN SEARCH FOR PARKINSON'S BIOMARKER

ACIU again has connections to MJFF - they got founded by them to develop their pipeline & research:
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43

ACIU currently only 200m market cap...!
Still flying completely under radar as you can see from volume history!
This should going into sky from now... Rare gem here!
$$$ACIU$$$